1,016
Views
27
CrossRef citations to date
0
Altmetric
Review

Biologic therapy in asthma: entering the new age of personalized medicine

, MD & , MD
Pages 669-676 | Received 07 Feb 2014, Accepted 26 Mar 2014, Published online: 13 May 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Girolamo Pelaia, Alessandro Vatrella, Maria Teresa Busceti, Luca Gallelli, Mariaimmacolata Preianò, Nicola Lombardo, Rosa Terracciano & Rosario Maselli. (2016) Role of biologics in severe eosinophilic asthma – focus on reslizumab. Therapeutics and Clinical Risk Management 12, pages 1075-1082.
Read now
Zhenghao Li, Jie Zheng, Ning Zhang & Chengde Li. (2016) Berberine improves airway inflammation and inhibits NF-κB signaling pathway in an ovalbumin-induced rat model of asthma. Journal of Asthma 53:10, pages 999-1005.
Read now

Articles from other publishers (25)

Su-Jong Kim, Jee Won Moon & Heung-Man Lee. (2021) Update on Biologics in Treatment of Chronic Rhinosinusitis With Nasal Polyposis. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 64:10, pages 693-702.
Crossref
Resti Yudhawati & Megawati Rif’atyyah Nozomi Guntur. (2021) Biological Therapy for Asthma. Jurnal Respirasi 7:1, pages 27.
Crossref
S. K. Zyryanov, S. N. Avdeev, D. A. Ivanov, M. V. Zhuravleva, N. P. Kniajeskaia, N. V. Matveev, N. A. Nenasheva, D. S. Fomina & M. Iu. Frolov. (2020) Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma. Terapevticheskii arkhiv 92:12, pages 172-179.
Crossref
Javier Checa & Josep M. Aran. (2020) Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology. International Journal of Molecular Sciences 21:23, pages 9317.
Crossref
Melina S. Nasta, Vasileios A. Chatzinakis & Christos C. Georgalas. (2020) Updates on current evidence for biologics in chronic rhinosinusitis. Current Opinion in Otolaryngology & Head & Neck Surgery 28:1, pages 18-24.
Crossref
Daljit S. Mann, Sukaina Hasnie & Kibwei A. McKinney. 2020. The Unified Airway. The Unified Airway 57 75 .
Louise Fleming & Liam Heaney. (2019) Severe Asthma—Perspectives From Adult and Pediatric Pulmonology. Frontiers in Pediatrics 7.
Crossref
Mehtap Haktanir Abul, Ahmad Salahaddine Naja, Anne Fitzpatrick, Wanda Phipatanakul & Louise Fleming. 2019. Severe Asthma. Severe Asthma 246 264 .
Alberta G. A. Paul, Lyndsey M. Muehling, Jacob D. Eccles & Judith A. Woodfolk. (2019) T cells in severe childhood asthma. Clinical & Experimental Allergy 49:5, pages 564-581.
Crossref
Kalliopi Domvri, Konstantinos Porpodis, Georgios Tzimagiorgis, Fani Chatzopoulou, Theodoros Kontakiotis, George Kyriazis & Despina Papakosta. (2019) Th2/Th17 cytokine profile in phenotyped Greek asthmatics and relationship to biomarkers of inflammation. Respiratory Medicine 151, pages 102-110.
Crossref
Anne S. Mainardi, Mario Castro & Geoffrey Chupp. (2019) Bronchial Thermoplasty. Clinics in Chest Medicine 40:1, pages 193-207.
Crossref
Rui Jiang, Yaping Jiang, Ping Xia, Guangwei Luo, Wei Huang, Zhimin Hu, Guilian Cheng, Yin Xiong, Yueqin Wang & Tianpen Cui. (2019) Cigarette Smoke Extract Promotes TIM4 Expression in Murine Dendritic Cells Leading to Th2 Polarization through ERK-Dependent Pathways. International Archives of Allergy and Immunology 178:3, pages 219-228.
Crossref
Kristine A. Smith, Abigail Pulsipher, David A. Gabrielsen & Jeremiah A. Alt. (2018) Biologics in Chronic Rhinosinusitis: An Update and Thoughts for Future Directions. American Journal of Rhinology & Allergy 32:5, pages 412-423.
Crossref
Michael S. Blaiss, Mario Castro, Bradley E. Chipps, Myron Zitt, Reynold A. PanettieriJr.Jr. & Michael B. Foggs. (2017) Guiding principles for use of newer biologics and bronchial thermoplasty for patients with severe asthma. Annals of Allergy, Asthma & Immunology 119:6, pages 533-540.
Crossref
Christian Domingo. (2017) Overlapping Effects of New Monoclonal Antibodies for Severe Asthma. Drugs 77:16, pages 1769-1787.
Crossref
Daniel M. Beswick, Stacey T. Gray & Timothy L. Smith. (2017) Pharmacological Management of Chronic Rhinosinusitis: Current and Evolving Treatments. Drugs 77:16, pages 1713-1721.
Crossref
Girolamo Pelaia, Alessandro Vatrella & Rosario MaselliGirolamo Pelaia, Alessandro Vatrella & Rosario Maselli. 2017. Asthma: Targeted Biological Therapies. Asthma: Targeted Biological Therapies 1 4 .
I. Mogensen, K. Alving, A. Bjerg, M. P. Borres, G. Hedlin, J. Sommar, S.-E. Dahl?n, C. Janson & A. Malinovschi. (2016) Simultaneously elevated exhaled nitric oxide and serum-eosinophil cationic protein relate to recent asthma events in asthmatics in a cross-sectional population-based study. Clinical & Experimental Allergy 46:12, pages 1540-1548.
Crossref
Steven K. Dennis, Kent Lam & Amber Luong. (2016) A Review of Classification Schemes for Chronic Rhinosinusitis with Nasal Polyposis Endotypes. Laryngoscope Investigative Otolaryngology 1:5, pages 130-134.
Crossref
Kent Lam, Robert C. Kern & Amber Luong. (2016) Is there a future for biologics in the management of chronic rhinosinusitis?. International Forum of Allergy & Rhinology 6:9, pages 935-942.
Crossref
Zoltán Sárkány, Kinga Sárkány & A. Horváth. (2016) Investigating the Possibility to Individualize Asthma Attack Therapy Based on Attack Severity and Patient Characteristics. Acta Medica Marisiensis 62:1, pages 73-77.
Crossref
Johannes RingJohannes Ring. 2016. Atopic Dermatitis. Atopic Dermatitis 129 166 .
Karen H. Calhoun. (2015) Asthma treatments: new and emerging therapies. International Forum of Allergy & Rhinology 5:S1, pages S76-S81.
Crossref
Paulina Barr?a P.Fernando Holguin F.Sally Wenzel S.. (2015) ASMA SEVERA EN ADULTOS: ENFOQUE DIAGN?STICO Y TRATAMIENTO. Revista M?dica Cl?nica Las Condes 26:3, pages 267-275.
Crossref
Gabriele GrunigAram BaghdassarianSung-Hyun ParkSerhiy PylawkaBertram BleckJoan ReibmanErika Berman-RosenzweigNedim Durmus. (2016) Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs. Biomarker Insights 10s4, pages BMI.S29514.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.